Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in PLX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$449,786
+$32,019 QoQ
Shares Held
207,275
-10.7% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $449,786 207,275
2025-12-31 $417,767 232,093
2025-09-30 $888,883 400,398
2025-06-30 $734,399 496,216
2025-03-31 $1,236,160 482,875
2023-12-31 $126,362 70,990
2023-09-30 $278,109 167,536
2023-06-30 $231,078 115,539
2023-03-31 $333,276 158,703